BiotechTube

Encapsulated Benzoyl Peroxide Cream

Phase 1Completed
0 watching 0 views this week💤 Quiet
25
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Papulopustular Rosacea

Conditions

Papulopustular Rosacea

Trial Timeline

Jun 10, 2020 → Jul 15, 2021

NCT ID
NCT05675501

About Encapsulated Benzoyl Peroxide Cream

Encapsulated Benzoyl Peroxide Cream is a phase 1 stage product being developed by Sol-Gel Technologies for Papulopustular Rosacea. The current trial status is completed. This product is registered under clinical trial identifier NCT05675501. Target conditions include Papulopustular Rosacea.

Hype Score Breakdown

Clinical
10
Activity
5
Company
2
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT05675501Phase 1Completed

Competing Products

18 competing products in Papulopustular Rosacea

See all competitors
ProductCompanyStageHype Score
Lotilaner Gel, 2.0%Tarsus PharmaceuticalsPhase 2
47
Deucravacitinib + PlaceboBristol Myers SquibbPhase 2
51
Topical Dapsone 5% Gel + oral antibioticsBristol Myers SquibbPhase 3
76
Azelaic acid (Finacea, BAY39-6251) + Metronidazole (Metrogel) + Doxycycline (Oracea)BayerApproved
82
Azelaic Acid foam 15%BayerApproved
82
Azelaic acid + Vehicle foamBayerPhase 2
49
Azelaic acid foam 15% + Vehicle foamBayerPhase 2
49
azelaic acid 15% gel + azelaic acid 15% gelBayerApproved
82
Azelaic Acid Foam + Azelaic Acid GelBayerPhase 1
30
Azelaic acid foam, 15% (BAY39-6251) + Vehicle foamBayerPhase 3
74
DFD-29 + Doxycycline + PlaceboDr. Reddy's LaboratoriesPhase 3
74
DFD-29 + Doxycycline + PlaceboDr. Reddy's LaboratoriesPhase 3
74
S5G4T-1Sol-Gel TechnologiesPhase 3
69
S5G4T-1 + S5G4T-2Sol-Gel TechnologiesPhase 3
69
S5G4T-1 + S5G4T-2Sol-Gel TechnologiesPhase 3
69
FMX103 minocycline foam 1.5% + Vehicle foamVyne TherapeuticsPhase 3
69
FMX103 1.5%Vyne TherapeuticsPhase 3
69
FMX103 minocycline foam 1.5% + Vehicle foamVyne TherapeuticsPhase 3
69

Other Products from Sol-Gel Technologies

S6G5T-3 + S6G5T-8Phase 3
69
5-FU Cream + Efudex® + VehiclePhase 3
69
Patidegib Topical Gel, 2% + Patidegib Topical Gel, VehiclePhase 3
69
S5G4T-1Phase 3
69
S5G4T-1 + S5G4T-2Phase 3
69